Trinity Biotech posts 2024 annual report, AGM materials

Trinity Biotech plc submitted a routine update that makes its full Annual Report 2024 available to investors.

Rhea-AI Filing Summary

Trinity Biotech plc submitted a routine update that makes its full Annual Report 2024 available to investors. The company is also distributing key materials for its upcoming annual general meeting to holders of its ordinary shares.

The documents provided include the 2024 annual report, a letter from the company secretary, the formal notice of the annual general meeting, and a proxy card that allows shareholders to vote by proxy. These materials are intended to help shareholders review the company’s performance over the past year and participate in governance decisions at the meeting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Trinity Biotech plc (TRIB) submit in this Form 6-K?

Trinity Biotech plc furnished its Annual Report 2024 and sent shareholders a company secretary letter, a notice of annual general meeting, and an AGM proxy card.

Which documents are attached to the Trinity Biotech (TRIB) September 2025 Form 6-K?

The submission includes four exhibits: the Trinity Biotech plc Annual Report 2024, a Company Secretary Letter, the Notice of Annual General Meeting, and an AGM Proxy Card.

How is the Trinity Biotech plc (TRIB) Annual Report 2024 being made available?

The Annual Report 2024 is furnished as Exhibit 99.1, making the company’s detailed yearly information available to investors and other stakeholders.

What shareholder meeting materials did Trinity Biotech (TRIB) send to ordinary shareholders?

Ordinary shareholders received a letter from the company secretary, a notice of annual general meeting, and a form of proxy to enable proxy voting at the AGM.

Is Trinity Biotech plc (TRIB) incorporating this Form 6-K into any registration statements?

Yes. This submission is incorporated by reference into Trinity Biotech plc’s Form S-8 registration statements with file numbers 333-182279, 333-195232, and 333-253070.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/08/2025 - 06:03 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

F O R M 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

TRINITY BIOTECH PLC

(Name of Registrant)

IDA Business Park

Bray, Co. Wicklow, Ireland

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒    Form 40-F ☐

This Form 6-K is being incorporated by reference into our Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070).

EXPLANATORY NOTE

A copy of the Trinity Biotech plc Annual Report 2024 is furnished herewith as Exhibit 99.1.

Trinity Biotech plc sent holders of its Ordinary Shares the following: “Letter from the Company Secretary of Trinity Biotech plc“, “Notice of Annual General Meeting“ and “Form of Proxy“. Copies of these documents are filed herewith as Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4 and incorporated herein by reference.

EXHIBIT INDEX

Exhibit		Description
99.1		Trinity Biotech plc Annual Report 2024
99.2		Trinity Biotech plc Company Secretary Letter
99.3		Trinity Biotech plc Notice of Annual General Meeting
99.4		Trinity Biotech plc AGM Proxy Card

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TRINITY BIOTECH PLC
		Trinity Biotech plc
		(Registrant)
	By:	/s/ John Gillard
		John Gillard
		Chief Executive Officer

Date:  September 8, 2025